382 related articles for article (PubMed ID: 25727150)
1. Glycosylation and liver cancer.
Mehta A; Herrera H; Block T
Adv Cancer Res; 2015; 126():257-79. PubMed ID: 25727150
[TBL] [Abstract][Full Text] [Related]
2. Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.
Mondal G; Saroha A; Bose PP; Chatterjee BP
Glycoconj J; 2016 Apr; 33(2):209-18. PubMed ID: 27034286
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma.
Comunale MA; Lowman M; Long RE; Krakover J; Philip R; Seeholzer S; Evans AA; Hann HW; Block TM; Mehta AS
J Proteome Res; 2006 Feb; 5(2):308-15. PubMed ID: 16457596
[TBL] [Abstract][Full Text] [Related]
4. N-Linked Glycan Branching and Fucosylation Are Increased Directly in Hcc Tissue As Determined through in Situ Glycan Imaging.
West CA; Wang M; Herrera H; Liang H; Black A; Angel PM; Drake RR; Mehta AS
J Proteome Res; 2018 Oct; 17(10):3454-3462. PubMed ID: 30110170
[TBL] [Abstract][Full Text] [Related]
5. Protein glycosylation in viral hepatitis-related HCC: Characterization of heterogeneity, biological roles, and clinical implications.
Zhang S; Cao X; Gao Q; Liu Y
Cancer Lett; 2017 Oct; 406():64-70. PubMed ID: 28789967
[TBL] [Abstract][Full Text] [Related]
6. Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma.
Comunale MA; Rodemich-Betesh L; Hafner J; Wang M; Norton P; Di Bisceglie AM; Block T; Mehta A
PLoS One; 2010 Aug; 5(8):e12419. PubMed ID: 20811639
[TBL] [Abstract][Full Text] [Related]
7. Integrating transcriptomics, glycomics and glycoproteomics to characterize hepatitis B virus-associated hepatocellular carcinoma.
Li Z; Zhang N; Dong Z; Wang X; Zhou J; Gao J; Yang Y; Li J; Guan F; Zhou Y; Tan Z
Cell Commun Signal; 2024 Apr; 22(1):200. PubMed ID: 38561745
[TBL] [Abstract][Full Text] [Related]
8. Molecular viral oncology of hepatocellular carcinoma.
Block TM; Mehta AS; Fimmel CJ; Jordan R
Oncogene; 2003 Aug; 22(33):5093-107. PubMed ID: 12910247
[TBL] [Abstract][Full Text] [Related]
9. Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma.
Liao J; Zhang R; Qian H; Cao L; Zhang Y; Xu W; Li J; Wu M; Yin Z
Biochem Biophys Res Commun; 2012 Apr; 420(2):308-14. PubMed ID: 22425980
[TBL] [Abstract][Full Text] [Related]
10. Glycosylation characteristics of colorectal cancer.
Holst S; Wuhrer M; Rombouts Y
Adv Cancer Res; 2015; 126():203-56. PubMed ID: 25727149
[TBL] [Abstract][Full Text] [Related]
11. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans.
Block TM; Comunale MA; Lowman M; Steel LF; Romano PR; Fimmel C; Tennant BC; London WT; Evans AA; Blumberg BS; Dwek RA; Mattu TS; Mehta AS
Proc Natl Acad Sci U S A; 2005 Jan; 102(3):779-84. PubMed ID: 15642945
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of tetra-antennary N-linked glycan but not core fucosylation are associated with hepatocellular carcinoma tissue.
Mehta A; Norton P; Liang H; Comunale MA; Wang M; Rodemich-Betesh L; Koszycki A; Noda K; Miyoshi E; Block T
Cancer Epidemiol Biomarkers Prev; 2012 Jun; 21(6):925-33. PubMed ID: 22490318
[TBL] [Abstract][Full Text] [Related]
13. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
[TBL] [Abstract][Full Text] [Related]
14. Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development.
Ringelhan M; Heikenwalder M; Protzer U
Dig Dis; 2013; 31(1):138-51. PubMed ID: 23797136
[TBL] [Abstract][Full Text] [Related]
15. Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and α2-6 Sialylation in Cancer.
Ferdosi S; Rehder DS; Maranian P; Castle EP; Ho TH; Pass HI; Cramer DW; Anderson KS; Fu L; Cole DEC; Le T; Wu X; Borges CR
J Proteome Res; 2018 Jan; 17(1):543-558. PubMed ID: 29129073
[TBL] [Abstract][Full Text] [Related]
16. Fucosylated glycoproteins as markers of liver disease.
Mehta A; Block TM
Dis Markers; 2008; 25(4-5):259-65. PubMed ID: 19126969
[TBL] [Abstract][Full Text] [Related]
17. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
18. Mass Spectrometric N-Glycan Analysis of Haptoglobin from Patient Serum Samples Using a 96-Well Plate Format.
Zhu J; Wu J; Yin H; Marrero J; Lubman DM
J Proteome Res; 2015 Nov; 14(11):4932-9. PubMed ID: 26448449
[TBL] [Abstract][Full Text] [Related]
19. Protein expression and fucosylated glycans of the serum haptoglobin-{beta} subunit in hepatitis B virus-based liver diseases.
Shu H; Zhang S; Kang X; Li S; Qin X; Sun C; Lu H; Liu Y
Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):528-34. PubMed ID: 21606158
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
